Mark Meltz was appointed CEO and general counsel at Kinnate Biopharma in San Diego, CA, in May. He joined Kinnate from another California company, Audentes Therapeutics, where he served as senior vice president and general counsel. He played a lead role in the sale of the company to Astellas Pharma in January.
2000
Mark Meltz
Mark Meltz was appointed CEO and general counsel at Kinnate Biopharma in San Diego, CA, in May. He joined Kinnate from another California company, Audentes Therapeutics, where he served as senior vice president and general counsel. He played a lead role in the sale of the company to Astellas Pharma in January.
